O'Donoghue M N
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.
Dermatol Clin. 1991 Oct;9(4):789-93.
It is hoped that this review has given some information to direct the clinician in his approach to his patients. Certainly, we would desire that the incidence of malignant melanoma as well as other skin cancers would start to decrease.